title: Osteoporosis in chronic obstructive pulmonary disease.
abstract: Chronic obstructive pulmonary disease (COPD) is a lifestyle-related chronic inflammatory pulmonary disease associated with significant morbidity and mortality worldwide. COPD is associated with various comorbidities found in all stages of COPD. The comorbidities have significant impact in terms of morbidity, mortality, and economic burden in COPD. Management of comorbidities should be incorporated into the comprehensive management of COPD as this will also have an effect on the outcome in COPD patients. Various comorbidities reported in COPD include cardiovascular disease, skeletal muscle dysfunction, anemia, metabolic syndrome, and osteoporosis. Osteoporosis is a significant comorbidity in COPD patients. Various risk factors, such as tobacco smoking, systemic inflammation, vitamin D deficiency, and the use of oral or inhaled corticosteroids (ICSs) are responsible for its occurrence in patients with COPD. This review will focus on the prevalence, pathogenesis, risk factors, diagnosis, and treatment of osteoporosis in COPD patients.
authors: Department of Pulmonary Medicine, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.
authors: Malay
authors: M
authors: Sarkar
authors: Department of Cardiology, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.
authors: Rajeev
authors: R
authors: Bhardwaj
authors: Department of Medical and Pediatric Oncology, GCRI, Ahmedabad, Gujarat, India.
authors: Irappa
authors: I
authors: Madabhavi
authors: Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.
authors: Jasmin
authors: J
authors: Khatana
keywords: COPD; RANK; osteoporosis; osteoprotegerin